Creative Biolabs has announced the expansion of its custom oligosaccharide synthesis and glycan characterization services, aiming to support researchers in drug discovery and biomedical research. The company combines advanced chemical, enzymatic, and chemoenzymatic synthesis technologies with comprehensive analytical platforms to provide structurally defined oligosaccharides with validated purity and composition.
Oligosaccharides play critical roles in cell signaling, immune regulation, pathogen-host interactions, and disease progression, making them valuable tools for developing therapeutics, vaccines, and diagnostics. However, their structural complexity poses significant challenges in synthesis, purification, and characterization, which can hinder research progress and experimental reproducibility.
“The structural complexity of oligosaccharides continues to present significant challenges for researchers developing next-generation therapeutics,” said a scientist from Creative Biolabs. “By integrating custom synthesis with comprehensive analytical characterization, we help researchers obtain structurally validated glycans that support reliable downstream studies and accelerate scientific discovery.”
Creative Biolabs offers a broad portfolio of services, including custom synthesis of high-purity oligosaccharides, complex glycans, tumor-associated carbohydrate antigens (TACAs), and functionalized carbohydrate derivatives. Advanced characterization techniques such as mass spectrometry (MS), high-performance liquid chromatography (HPLC), and nuclear magnetic resonance (NMR) are employed to determine glycan structures, linkage patterns, sequences, and purity.
The integrated platform also provides application-oriented carbohydrate design for structural biology, glycoprotein research, biomarker discovery, immunology, targeted drug delivery, and therapeutic development. By combining synthesis and analysis under one roof, Creative Biolabs helps researchers reduce technical risks, improve experimental reproducibility, and accelerate project progression.
In one recent project, researchers required a complex glycan structure not readily available through standard commercial sources. The integrated synthesis and analytical characterization supported downstream structural confirmation, highlighting the quality of products and comprehensive technical support provided.
Researchers can explore customized oligosaccharide synthesis and glycan characterization options through Creative Biolabs' glycobiology platform at https://www.creative-biolabs.com/glycoprotein/.
